Search research articles
Contact Us
Filters
Showing results (81-90 of 105) with videos related to
Page
of 11
Sort By:
Nature Communications
|
September 24, 2021
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
Guangchun Han, Guoliang Yang, Dapeng Hao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2022
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma
Jason Westin, R Eric Davis, Lei Feng, et al.
The Lancet. Oncology
|
February 5, 2026
Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaboration
Chad Tang, Alex D Sherry, Hyunsoo Hwang, et al.
Nature Medicine
|
October 6, 2020
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
Qing Deng, Guangchun Han, Nahum Puebla-Osorio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2022
Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer
Clinton Yam, Nour Abuhadra, Ryan Sun, et al.
Cancers
|
July 14, 2023
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial
Nour Abuhadra, Ryan Sun, Clinton Yam, et al.
The Lancet. Gastroenterology & Hepatology
|
January 22, 2022
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
Ahmed Omar Kaseb, Elshad Hasanov, Hop Sanderson Tran Cao, et al.
JAMA Oncology
|
September 12, 2024
Molecular, Socioeconomic, and Clinical Factors Affecting Racial and Ethnic Disparities in Colorectal Cancer Survival
Mahmoud Yousef, Abdelrahman Yousef, Saikat Chowdhury, et al.
Blood
|
February 3, 2021
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma
Paolo Strati, Sairah Ahmed, Fateeha Furqan, et al.
Cancer Cell
|
September 8, 2025
Large B cell lymphoma microenvironment archetype profiles
Xubin Li, Kartik Singhal, Qing Deng, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 105) with videos related to
Sort By:
Page
of 11
Nature Communications
|
September 24, 2021
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
Guangchun Han, Guoliang Yang, Dapeng Hao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2022
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma
Jason Westin, R Eric Davis, Lei Feng, et al.
The Lancet. Oncology
|
February 5, 2026
Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaboration
Chad Tang, Alex D Sherry, Hyunsoo Hwang, et al.
Nature Medicine
|
October 6, 2020
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
Qing Deng, Guangchun Han, Nahum Puebla-Osorio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2022
Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer
Clinton Yam, Nour Abuhadra, Ryan Sun, et al.
Cancers
|
July 14, 2023
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial
Nour Abuhadra, Ryan Sun, Clinton Yam, et al.
The Lancet. Gastroenterology & Hepatology
|
January 22, 2022
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
Ahmed Omar Kaseb, Elshad Hasanov, Hop Sanderson Tran Cao, et al.
JAMA Oncology
|
September 12, 2024
Molecular, Socioeconomic, and Clinical Factors Affecting Racial and Ethnic Disparities in Colorectal Cancer Survival
Mahmoud Yousef, Abdelrahman Yousef, Saikat Chowdhury, et al.
Blood
|
February 3, 2021
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma
Paolo Strati, Sairah Ahmed, Fateeha Furqan, et al.
Cancer Cell
|
September 8, 2025
Large B cell lymphoma microenvironment archetype profiles
Xubin Li, Kartik Singhal, Qing Deng, et al.
Page
of 11